Valuation: Danaher Corporation

Market Cap 142B 124B 115B 105B 200B 13,674B 203B 1,368B 537B 6,684B 534B 522B 23,037B P/E 2026 *
32.5x
P/E 2027 * 26.8x
Enterprise Value 164B 144B 132B 122B 231B 15,801B 235B 1,581B 620B 7,723B 617B 603B 26,620B EV / Sales 2026 *
6.29x
EV / Sales 2027 * 5.52x
Free-Float
71.14%
Yield 2026 *
0.71%
Yield 2027 * 0.76%
1 day+2.37%
1 week+5.25%
Current month+5.41%
1 month+10.87%
3 months+1.34%
6 months-16.30%
Current year-12.29%
1 week 195.05
Extreme 195.05
202.36
1 month 174.22
Extreme 174.2162
202.36
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
333.96
10 years 75.71
Extreme 75.71
333.96
Manager TitleAgeSince
Chief Executive Officer 62 31/08/2020
Director of Finance/CFO - 27/02/2026
Chief Tech/Sci/R&D Officer - 24/08/2025
Director TitleAgeSince
Director/Board Member 74 30/06/1999
Chairman 74 31/12/1983
Director/Board Member 69 31/12/1983
Date Insider Type Main position Quantity % Market Cap.
05-14Free

Director

2,379 0.0003%
05-14Free

Director

2,379 0.0003%
05-14Free

Director

2,379 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+0.87%+5.25%+4.11%-16.52% 142B
+0.23%+4.93%+28.06%+1.12% 199B
+2.50%-6.29%-24.06%+9.88% 138B
+0.96%-3.95%-58.41%-18.84% 63.97B
-3.13%-6.80%+13.62%-6.54% 50.25B
+0.72%+1.86%-24.05%-32.00% 44.33B
-0.36%+4.37%+19.28%+12.49% 38.05B
-0.39%+1.84%+29.48%+38.46% 36.81B
+2.50%-2.29%-15.04%-22.76% 28.75B
+2.88%-3.53%-21.21%-10.69% 28.64B
Average +0.61%-1.66%-4.82%-4.54% 76.96B
Weighted average by Cap. +0.40%-0.27%-0.63%-3.62%

Financials

2026 *2027 *
Net sales 26.11B 22.83B 21.06B 19.36B 36.68B 2,512B 37.3B 251B 98.64B 1,228B 98.05B 95.9B 4,232B 28.41B 24.84B 22.91B 21.06B 39.91B 2,734B 40.59B 274B 107B 1,336B 107B 104B 4,605B
Net income 4.42B 3.86B 3.56B 3.27B 6.2B 425B 6.31B 42.53B 16.69B 208B 16.59B 16.22B 716B 5.35B 4.68B 4.31B 3.96B 7.51B 515B 7.64B 51.49B 20.2B 252B 20.08B 19.64B 867B
Net Debt 22.11B 19.33B 17.83B 16.39B 31.05B 2,127B 31.58B 213B 83.51B 1,040B 83.01B 81.2B 3,583B 14.57B 12.74B 11.75B 10.8B 20.46B 1,402B 20.81B 140B 55.03B 685B 54.7B 53.5B 2,361B
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
15/07/26 US$200.79 +0.87% 4,373,205
14/07/26 US$199.05 -0.55% 4,188,554
13/07/26 US$200.16 +0.56% 2,918,894
10/07/26 US$199.05 +1.57% 3,847,652
09/07/26 US$195.98 +2.73% 2,657,124
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
200.79USD
Average target price
242.52USD
Spread / Average Target
+20.78%

Quarterly revenue - Rate of surprise